Ryu MH - Search Results

1

[Clinicopathologic characteristics of colorectal neuroendocrine tumor].

Jung SH, Kim HC, Yu CS, Chang HM, Ryu MH, Lee JL, Kim JS, Kim JC. Jung SH, et al. Among authors: ryu mh. Korean J Gastroenterol. 2006 Aug;48(2):97-103. Korean J Gastroenterol. 2006. PMID: 16929153 Korean.

2

Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors.

Kim TW, Lee H, Kang YK, Choe MS, Ryu MH, Chang HM, Kim JS, Yook JH, Kim BS, Lee JS. Kim TW, et al. Among authors: ryu mh. Clin Cancer Res. 2004 May 1;10(9):3076-81. doi: 10.1158/1078-0432.ccr-03-0581. Clin Cancer Res. 2004. PMID: 15131046

3

Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy.

Heo YS, Chang HM, Kim TW, Ryu MH, Ahn JH, Kim SB, Lee JS, Kim WK, Cho HK, Kang YK. Heo YS, et al. Among authors: ryu mh. J Clin Pharmacol. 2004 Oct;44(10):1166-72. doi: 10.1177/0091270004268321. J Clin Pharmacol. 2004. PMID: 15342618

4

Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer.

Kim JC, Kim TW, Kim JH, Yu CS, Kim HC, Chang HM, Ryu MH, Park JH, Ahn SD, Lee SW, Shin SS, Kim JS, Choi EK. Kim JC, et al. Among authors: ryu mh. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):346-53. doi: 10.1016/j.ijrobp.2005.02.046. Int J Radiat Oncol Biol Phys. 2005. PMID: 15913913 Clinical Trial.

5

Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate.

Ryu MH, Lee JL, Chang HM, Kim TW, Kang HJ, Sohn HJ, Lee JS, Kang YK. Ryu MH, et al. Jpn J Clin Oncol. 2006 Jan;36(1):17-24. doi: 10.1093/jjco/hyi212. Epub 2006 Jan 17. Jpn J Clin Oncol. 2006. PMID: 16418188

6

Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.

Kim JC, Kim HC, Lee KH, Yu CS, Kim TW, Chang HM, Ryu MH, Kim JH, Ha HK, Lee MG. Kim JC, et al. Among authors: ryu mh. J Gastroenterol Hepatol. 2006 Jun;21(6):1026-35. doi: 10.1111/j.1440-1746.2005.04023.x. J Gastroenterol Hepatol. 2006. PMID: 16724990 Clinical Trial.

7

Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.

Lee JL, Kim JY, Ryu MH, Kang HJ, Chang HM, Kim TW, Lee H, Park JH, Kim HC, Kim JS, Kang YK. Lee JL, et al. Among authors: ryu mh. Dig Dis Sci. 2006 Jun;51(6):1043-6. doi: 10.1007/s10620-006-8003-1. Dig Dis Sci. 2006. PMID: 16865565 No abstract available.

8

A case of leukemic pleural infiltration in atypical chronic myeloid leukemia.

Kim HW, Lee SS, Ryu MH, Lee JL, Chang HM, Kim TW, Chi HS, Kim WK, Lee JS, Kang YK. Kim HW, et al. Among authors: ryu mh. J Korean Med Sci. 2006 Oct;21(5):936-9. doi: 10.3346/jkms.2006.21.5.936. J Korean Med Sci. 2006. PMID: 17043433 Free PMC article.

9

Clinical outcome in gastrointestinal stromal tumor patients who interrupted imatinib after achieving stable disease or better response.

Lee JL, Ryu MH, Chang HM, Kim TW, Kang HJ, Sohn HJ, Lee JS, Kang YK. Lee JL, et al. Among authors: ryu mh. Jpn J Clin Oncol. 2006 Nov;36(11):704-11. doi: 10.1093/jjco/hyl088. Epub 2006 Oct 26. Jpn J Clin Oncol. 2006. PMID: 17068083

10

Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer.

Yu CS, Kim TW, Kim JH, Choi WS, Kim HC, Chang HM, Ryu MH, Jang SJ, Ahn SD, Lee SW, Shin SS, Choi EK, Kim JC. Yu CS, et al. Among authors: ryu mh. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1020-6. doi: 10.1016/j.ijrobp.2006.10.013. Epub 2006 Dec 29. Int J Radiat Oncol Biol Phys. 2007. PMID: 17197127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

425 results

Search Page

Filters